Literature DB >> 11769571

Pathophysiology and management of irritable bowel syndrome.

J E Kellow1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11769571      PMCID： PMC4531728          DOI： 10.3904/kjim.2001.16.3.137

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN： 1226-3303            Impact factor:   2.884


× No keyword cloud information.
  44 in total

Review 1.  Review article: tegaserod.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

2.  Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints.

Authors:  R Goldstein; D Braverman; H Stankiewicz
Journal:  Isr Med Assoc J       Date:  2000-08       Impact factor: 0.892

Review 3.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

Review 4.  Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

Authors:  J Jailwala; T F Imperiale; K Kroenke
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

5.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

6.  The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.

Authors:  I Heymann-Mönnikes; R Arnold; I Florin; C Herda; S Melfsen; H Mönnikes
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 7.  5-Hydroxytryptamine and functional bowel disorders.

Authors:  G J Sanger
Journal:  Neurogastroenterol Motil       Date:  1996-12       Impact factor: 3.598

8.  Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features.

Authors:  P R Evans; E J Bennett; Y T Bak; C C Tennant; J E Kellow
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

9.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

Review 10.  Review article: the hypersensitive gut--peripheral kappa agonists as a new pharmacological approach.

Authors:  J L Junien; P Riviere
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171
View more
  3 in total

Review 1.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

2.  Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database.

Authors:  Hye-Kyung Jung; Youn Hee Kim; Joo Yeon Park; Bo Hyoung Jang; Sun-Young Park; Mi-Hee Nam; Myung-Gyu Choi
Journal:  J Neurogastroenterol Motil       Date:  2014-04-30       Impact factor: 4.924

Review 3.  Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea.

Authors:  Konstantinos C Fragkos
Journal:  Clin Exp Gastroenterol       Date:  2017-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.